A Canadian perspective on the American Academy of Pediatrics guidelines for acute otitis media

Paediatrics and Child Health

Volumn 12, Issue 7, 2007, Pages 579-581

  Salvadori, Marina ^a   Kakkar, Fatima ^a   Sumpton, Janice ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFDINIR; CEFPODOXIME; CEFUROXIME AXETIL; CEPHALOSPORANIC ACID DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ACUTE OTITIS MEDIA; ANAPHYLAXIS; ANTIBIOTIC THERAPY; CANADA; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SUBSTITUTION; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION PREVENTION; MEDICAL SOCIETY; MORAXELLA CATARRHALIS; PENICILLIN ALLERGY; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; URTICARIA;

EID: 35948939627     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.
2. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media - management and surveillance in an era of pneumoccocal resistance - a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9. (Erratum in 1999;18:341).
3. Canadian Paediatric Society, Infectious Diseases and Immunization Committee [Principal author: D Speert]. Antibiotic management of acute otitis media. Paediatr Child Health 1998;3:265-7.
4. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004;23:824-8.
5. Garbutt J, Rosenbloom I, Wu J, Storch GA. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine. Pediatrics 2006;117:e1087-94.
6. Hedrick JA, Sher LD, Schwartz RH, Pierce P. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media. Clin Ther 2001;23:193-204.
7. Leibovitz E. Acute otitis media in pediatric medicine: Current issues in epidemiology, diagnosis, and management. Paediatr Drugs 2003;5(Suppl 1):1-12.
8. Steele RW, Thomas MP, Bégué RE. Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J 2001;20:1-5.
9. Powers JL, Gooch WM, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs amoxicillin/clavulanate potassium, cefprozil, and azithromycin in pediatric patients. Pediatr Infect Dis J 2000;19(12 Suppl):S174-80.
10. Gooch WM, Blair E, Puopolo A, et al. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J 1996;15:157-64.
11. Block SL, McCarty JM, Hedrick JA, Nemeth MA, Keyserling CH, Tack KJ; Cefdinir Otitis Media Study Group. Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J 2000;19(12 Suppl):S159-65.
12. Pelton SI. Otitis media: Re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am 2005;52:711-28, v-vi.
13. Trujillo M, Correa N, Olsen K, et al. Cefprozil concentrations in middle ear fluid of children with acute otitis media. Pediatr Infect Dis J 2000;19:268-70.